Under the supervision of Dr. Thomas Wagner, Orbis Health Solutions has developed a vaccine currently in phase 3 clinical trials. This vaccine promises to revolutionize cancer treatment by optimizing the effectiveness of the immune system, while considerably minimizing side effects, ABC reports.
A cancer vaccine with minimal side effects is nearing Phase 3 clinical trials, experts say. Here's what to know: https://t.co/Bm1dZhlXX0 pic.twitter.com/qJvNoVKlTk
— ABC News (@ABC) January 21, 2024
Significant progress has recently been made in the fight against cancer, notably with the emergence of a vaccine treatment that raises hopes of a possible cure for patients suffering from melanoma, a particularly serious form of skin cancer.
The vaccine offers an immune therapy designed to boost the body’s response against cancer cells. It takes advantage of the body’s natural recognition process, teaching it to target cancer cells by identifying them as invaders.
Phase 2 clinical trial results for this vaccine were encouraging, in participants with advanced melanoma. The combination of Keytruda treatment and mRNA vaccine demonstrated a significant 49% reduction in the risk of disease recurrence or death, as well as a 62% reduction in distant tumor spread or death at 3-year follow-up.
Advanced melanoma patients treated with both Keytruda and the mRNA vaccine had significantly lower risks of recurrence and death than those treated with Keytruda alone.
Around 500 participants will be selected for the start of phase 3 of the clinical trial, in the hope that this more extensive investigation will confirm the vaccine’s efficacy.
The vaccine is not only effective, but also has minimal side effects, mainly a reaction at the injection site, fatigue and fever. Despite a 25% rate of more serious side effects, the treatment profile of Keytruda and the vaccine is deemed acceptable given the severity of the disease.
The medical community and cancer survivors eagerly anticipate the advent of a more compassionate approach to cancer treatment in this new era of cancer therapy. Personalization and immunotherapy could become the foundations of effective treatments, dramatically reducing the severe side effects associated with past treatment.
More precise cancer treatments symbolize medical innovation, offering renewed hope to millions of people affected by cancer. The medical community and cancer survivors alike are eager to see the progress of clinical trials of these promising vaccines.